Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant

Zhu, W., Ding, Z., Zhang, Y., Shi, J., Hashimoto, K., & Lu, L. | Neuroscience Bulletin | 22 November 2016

Ketamine: The Glutamatergic Antidepressant and Its Efficacy

Tracy, D. K., Caddy, C., & Shergill, S. S. | Melatonin, Neuroprotective Agents and Antidepressant Therapy | 18 November 2016

Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use

Morgan, C., McAndrew, A., Stevens, T., Nutt, D., & Lawn, W. | Current Opinion in Behavioral Sciences | 15 November 2016

Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies

Han, Y., Chen, J., Zou, D., Zheng, P., Li, Q., Wang, H., ... & Xie, P. | Neuropsychiatric Disease and Treatment | 3 November 2016

Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression

Papp, M., Gruca, P., Lason-Tyburkiewicz, M., & Willner, P. | Behavioural Pharmacology | 18 October 2016

A Double-Blinded, Randomized, Placebo-Controlled Sub-Dissociative Dose Ketamine Pilot Study in the Treatment of Acute Depression and Suicidality in a Military Emergency Department Setting

Burger, J., Capobianco, M., Lovern, R., Boche, B., Ross, E., Darracq, M. A., & McLay, R. | Military Medicine | 1 October 2016

Clinical and biological predictors of ketamine response in treatment-resistant major depression: Review

Romeo, B., Choucha, W., Fossati, P., & Rotge, J. Y. | L'Encephale | 9 September 2016

Ketamine Treatment and Global Brain Connectivity in Major Depression

Abdallah, C. G., Averill, L. A., Collins, K. A., Geha, P., Schwartz, J., Averill, C., ... & Iosifescu, D. V. | Neuropsychopharmacology | 8 September 2016

Ketamine for Depression: An Update

Murrough, J. W. | Biological Psychiatry | 24 August 2016

The antidepressant effect of ketamine: Mediated by AMPA receptors?

Inta, D., Sprengel, R., Borgwardt, S., Lang, U. E., & Gass, P. | European Neuropsychopharmacology | 20 August 2016

New use for an old drug: oral ketamine for treatment-resistant depression

Swiatek, K. M., Jordan, K., & Coffman, J. | BMJ Case Reports | 3 August 2016

Neurovascular Plasticity of the Hippocampus One Week after a Single Dose of Ketamine in Genetic Rat Model of Depression

Ardalan, M., Wegener, G., Polsinelli, B., Madsen, T. M., & Nyengaard, J. R. | Hippocampus | 21 July 2016

Efficacy and safety of ketamine in bipolar depression: A systematic review

Alberich, S., Martínez-Cengotitabengoa, M., López, P., Zorrilla, I., Núñez, N., Vieta, E., & González-Pinto, A. | Revista de psiquiatria y salud mental | 4 July 2016

Clinical Applications of Hallucinogens: A Review

Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. | Experimental and clinical psychopharmacology | 1 July 2016

Major Depressive Disorder Induced by Chronic Ketamine Abuse: A Case Report

Chang, H., Huang, M. C., & Chen, L. Y. | The Primary Care Companion for CNS Disorders | 23 June 2016

Letter to the Editor: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity

Hashimoto, K. | Psychological medicine | 10 June 2016

Potential involvement of serotonergic signaling in ketamine’s antidepressant actions: A critical review

du Jardin, K. G., Müller, H. K., Elfving, B., Dale, E., Wegener, G., & Sanchez, C. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2 June 2016

Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial

Jafarinia, M., Afarideh, M., Tafakhori, A., Arbabi, M., Ghajar, A., Noorbala, A. A., ... & Akhondzadeh, S. | Journal of Affective Disorders | 1 June 2016

Ketamine abuse potential and use disorder

Liu, Y., Lin, D., Wu, B., & Zhou, W. | Brain research bulletin | 31 May 2016

Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior

Mallick, F., & McCullumsmith, C. B. | Current psychiatry reports | 19 May 2016

Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits

Zhang, M. W., & Ho, R. C. | Ethics & Behavior | 17 May 2016

Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression

Zhong, X., He, H., Zhang, C., Wang, Z., Jiang, M., Li, Q., ... & Huang, X. | Journal of Affective Disorders | 12 May 2016

Glutamate and GABA Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine

Lener, M. S., Niciu, M. J., Ballard, E. D., Park, M., Park, L. T., Nugent, A., & Zarate, C. A. | Biological Psychiatry | 12 May 2016

Ketamine: stimulating antidepressant treatment?

Malhi, G. S., Byrow, Y., Cassidy, F., Cipriani, A., Demyttenaere, K., Frye, M. A., ... & McShane, R. | British Journal of Psychiatry Open | 11 May 2016

Depression: Ketamine steps out of the darkness

Malinow, R. | Nature | 4 May 2016